K2X Technology & Life Science, Inc.
KBPH
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Net Income | 1.13M | 810.10K | 132.10K | 427.00K | -85.90K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.42M | -2.09M | -1.22M | -1.17M | -788.60K |
| Change in Net Operating Assets | -2.83M | -3.35M | -2.74M | -1.73M | -2.82M |
| Cash from Operations | -4.11M | -4.63M | -3.82M | -2.47M | -3.69M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 250.00K | 0.00 | -425.00K |
| Total Debt Issued | -3.30K | -3.30K | 0.00 | 0.00 | 2.10K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 129.50K | 1.70M | 1.70M | 1.57M | 1.57M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 4.00M | 2.86M | 2.48M | 2.30M | 2.05M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 36.40K | 0.00 | 0.00 | 0.00 | 219.80K |
| Cash from Financing | 4.16M | 4.55M | 4.18M | 3.87M | 3.84M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.40K | -81.30K | 355.20K | 1.40M | 145.20K |
